Skip to content
BritTM
← Back to search

International registration designating the UK WO0000001297361

POMOZA

ProtectedWord
TM

Text representation

Trade mark image

Generated from the official word element so every word-mark card has a visual. It is not an official figurative logo.

Text representation of trade mark WO0000001297361 — POMOZA
Generated from the official word element · not an official figurative logo

Registration details

Trade mark number
WO0000001297361
Status in snapshot
Protected
Filed / designated
12 May 2016
Published
20 May 2016
Registered / protected
21 Jul 2016
International registration valid until
5 Apr 2026 · WIPO update 27 Oct 2026
Expired
Not supplied
Category
Standard
Mark type
Word

Owner

Nice classes

5

Official source data

Additional trade mark details

Current Madrid designations
AG, AL, AM, AT, AU, AZ, BA, BG, BH, BQ, BT, BW, BX, BY, CH, CN, CO, CU, CW, CY, CZ, DE, DK, DZ, EE, EG, EM, ES, FI, FR, GB, GE, GH, GM, GR, HR, HU, IE, IL, IN, IR, IS, IT, JP, KE, KG, KH, KR, KZ, LA, LI, LR, LS, LT, LV, MA, MC, MD, ME, MG, MK, MN, MX, MZ, NA, NO, NZ, OA, OM, PH, PL, PT, RO, RS, RU, RW, SD, SE, SG, SI, SK, SL, SM, ST, SX, SY, SZ, TJ, TM, TN, TR, UA, UZ, VN, ZM, ZW
International registration valid until
2026-04-05
International registration date
2016-04-05
WIPO office of origin
US
Representative recorded by WIPO
KIRKPATRICK, SA/NV

Nice classification

Goods and services

Wording supplied in the official WIPO ROMARIN update WIPO-20261027.

Class 5

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.